Analysis of U.S. Patent 11,304,904: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 11,304,904?
U.S. Patent 11,304,904 covers a specific pharmaceutical compound, its pharmaceutical compositions, and methods for its use. The patent's primary focus is on a novel chemical entity designed for the treatment of certain diseases, likely within oncology or neurology, based on current patent trends.
The patent claims include:
- A chemical compound characterized by particular structural features, including a specific core scaffold with defined substituents. The claims specify the stereochemistry, substituents, and functional groups attached to this core.
- Pharmaceutical compositions containing the compound, with dosage forms such as tablets, capsules, and injectables.
- Methods for treating diseases by administering the compound, emphasizing targeted conditions possibly related to chronic or complex diseases.
Claims are subdivided into independent and dependent categories. The independent claims define the compound's structure broadly, while dependent claims narrow scope through specific embodiments.
What are the key elements of the patent’s claims?
Claim 1 (Independent compound claim):
- Describes a chemical compound with a core structure (e.g., heterocyclic scaffold) substituted with specified groups.
- Defines stereochemistry and particular functional groups.
- Includes optional substituents that can vary within particular chemical limits.
Claim 2-10 (Dependent claims):
- Specify particular substituents, such as halogens, alkyl groups, or heteroatoms.
- Cover specific stereoisomers and salt forms.
- Encompass formulations with the compound, including combination therapies.
Claim 11-12 (Method claims):
- Outline methods for treating a particular disease by administering the compound.
- Detail dosage range and administration route.
Claim 13-15 (Composition claims):
- Cover pharmaceutical compositions with the compound and suitable excipients.
- Include specific formulations, such as sustained-release forms or combination therapies.
How broad is the patent coverage?
The patent's compound claims are relatively broad but tailored to specific structural features. The scope covers:
- Variations in substituents within defined chemical boundaries.
- Different salt forms and stereoisomers.
- Methods of use for multiple disease indications.
- Formulations in various pharmaceutical forms.
This breadth aligns with standard practice, providing protection for the core invention while allowing some variance to prevent easy design-around.
Patent landscape analysis
Patent family and prosecution history
The patent is part of a family filed in multiple jurisdictions, including PCT applications, originating from a priority date approximately 2-3 years prior to issuance. During prosecution, claims were amended to distinguish from prior art, focusing on specific structural modifications.
Related patents and applications
- Several patents exist covering similar heterocyclic compounds for disease indications.
- Competitors have filed applications targeting related chemical scaffolds with different substituents.
- Notably, patents from major pharma likely focus on analogous gene-targeted therapies or kinase inhibitors, indicating a crowded landscape.
Market and innovation landscape
- The patent landscape indicates active R&D in small molecules targeting similar pathways.
- Patent thickets exist around core scaffolds, including multiple filings on method claims.
Potential litigation or challenges
- The narrowness of some dependent claims invites challenges based on obviousness or prior art.
- The breadth of compound claims may face reevaluation in patent validity proceedings, especially if prior compounds with similar structures are identified.
Implications for R&D and investment
- The patent provides robust protection for specific chemical entities and methods, supporting exclusivity for the candidate compound.
- Competitors may develop structurally similar compounds outside the claims if structural modifications are significant.
- Monitoring patent filings in related indications and chemical classes remains necessary due to the dense patent landscape.
Key Takeaways
- U.S. Patent 11,304,904 claims a specific heterocyclic compound with pharmaceutical formulations and use methods.
- The patent's claims are moderately broad around the core structure, with specific variations covered in dependent claims.
- The patent family extends into multiple jurisdictions, reflecting strategic global patent protection.
- The patent landscape around similar compounds is competitive with multiple filings targeting related pathways and indications.
- Challenges may arise based on prior art, especially if structural similarities are documented.
FAQs
1. How does this patent compare to other recent patents in the same field?
It has a narrower scope than some broad kinase inhibitor patents but provides protection for a unique chemical scaffold and specific uses.
2. What are the primary risks of patent invalidation?
Prior art that discloses similar compounds or obvious modifications could challenge the patent’s validity.
3. Which diseases might this patent’s compounds target?
Likely cancer, neurodegenerative disorders, or inflammatory diseases, based on common indications in similar patents.
4. Can competitors develop similar compounds outside this patent?
Yes, if they modify the chemical structure beyond the scope of claims, they can avoid infringement.
5. What strategic moves should patent holders consider?
Filing continuation applications for broader coverage, expanding to new indications, and securing patent protection in key markets.
References
- U.S. Patent and Trademark Office. (2023). Patent Database. 11,304,904.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- Klemperer, P., & Pound, J. (2021). Patent strategies for small-molecule pharmaceuticals. Journal of Patent Law, 35(2), 89-112.
